Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322774714> ?p ?o ?g. }
- W4322774714 endingPage "135247" @default.
- W4322774714 startingPage "135247" @default.
- W4322774714 abstract "In this study, 16 new hybrid compounds 6(a-h) and 7(a-h) were synthesized starting from methylparaben. These new compounds consist of eight 1,2,3-triazole-arylidenehydrazide derivatives and eight 1,2,3-triazole-thiazolidin-4-one derivatives. All compounds were tested against MCF-7 breast cancer cells and MCF10A breast healthy tissue to determine their anti-cancer activity. Molecular docking studies were also carried out against receptor proteins (HER2, EGFR, and VEGFR1) that are related to the growth factor of cancer cells to understand the inhibition mechanism. According to the results of in silico and in vitro activity studies, compounds 6g and 7g were found as the highest selective and active against breast cancer cells. The IC50 values of compounds 6g and 7g against MCF7 cells were found as 8.48 and 4.38 µM, respectively. In addition, the IC50 values of compounds 6g and 7g against MCF10A cells were found as 114.80 and 170.60 µM. When comparing the selectivity of the 6g and 7g to the reference drug doxorubicin, 6g and 7g had higher selectivity (13.5 and 39 respectively) compared to doxorubicin (4). The compound 7g also showed activity against cancer cells at lower doses and was found to be safe against healthy cells at high doses. Molecular docking results showed that both 6g and 7g had higher binding scores for all 3 target enzymes and especially for HER2 protein related to breast cancer with binding scores of -8.059 kcal and -9,008 kcal respectively, while doxorubicin had a binding score of -7.854 kcal. According to the results of the in vitro, and in silico study, compound 7g which was synthesized in this study is a promising, potent, and selective anti-cancer drug candidate for the treatment of breast cancer. All the tested compounds were very well characterized by spectroscopic methods and they have at least 95% HPLC purity." @default.
- W4322774714 created "2023-03-03" @default.
- W4322774714 creator A5042219288 @default.
- W4322774714 creator A5049326880 @default.
- W4322774714 creator A5074439787 @default.
- W4322774714 creator A5076060387 @default.
- W4322774714 date "2023-07-01" @default.
- W4322774714 modified "2023-10-18" @default.
- W4322774714 title "Synthesis, characterization, molecular docking and in vitro anti-cancer activity studies of new and highly selective 1,2,3-triazole substituted 4-hydroxybenzohyrdazide derivatives" @default.
- W4322774714 cites W1985570405 @default.
- W4322774714 cites W2020681885 @default.
- W4322774714 cites W2059333644 @default.
- W4322774714 cites W2112923693 @default.
- W4322774714 cites W2259013233 @default.
- W4322774714 cites W2278317424 @default.
- W4322774714 cites W2556015468 @default.
- W4322774714 cites W2591198701 @default.
- W4322774714 cites W2754627070 @default.
- W4322774714 cites W2788166312 @default.
- W4322774714 cites W2795923372 @default.
- W4322774714 cites W2803917280 @default.
- W4322774714 cites W2805889302 @default.
- W4322774714 cites W2911188335 @default.
- W4322774714 cites W2912993657 @default.
- W4322774714 cites W2913879165 @default.
- W4322774714 cites W2950417160 @default.
- W4322774714 cites W2951071083 @default.
- W4322774714 cites W2959942305 @default.
- W4322774714 cites W2964702710 @default.
- W4322774714 cites W2979291688 @default.
- W4322774714 cites W3005176975 @default.
- W4322774714 cites W3015238602 @default.
- W4322774714 cites W3087860232 @default.
- W4322774714 cites W3097323536 @default.
- W4322774714 cites W3110579430 @default.
- W4322774714 cites W3128446345 @default.
- W4322774714 cites W3133840085 @default.
- W4322774714 cites W3147142721 @default.
- W4322774714 cites W3168190735 @default.
- W4322774714 cites W3186789411 @default.
- W4322774714 cites W3193869551 @default.
- W4322774714 cites W3213313190 @default.
- W4322774714 cites W4220881730 @default.
- W4322774714 cites W4220957424 @default.
- W4322774714 cites W4280605132 @default.
- W4322774714 cites W4313482880 @default.
- W4322774714 cites W4313892082 @default.
- W4322774714 doi "https://doi.org/10.1016/j.molstruc.2023.135247" @default.
- W4322774714 hasPublicationYear "2023" @default.
- W4322774714 type Work @default.
- W4322774714 citedByCount "7" @default.
- W4322774714 countsByYear W43227747142023 @default.
- W4322774714 crossrefType "journal-article" @default.
- W4322774714 hasAuthorship W4322774714A5042219288 @default.
- W4322774714 hasAuthorship W4322774714A5049326880 @default.
- W4322774714 hasAuthorship W4322774714A5074439787 @default.
- W4322774714 hasAuthorship W4322774714A5076060387 @default.
- W4322774714 hasConcept C104317684 @default.
- W4322774714 hasConcept C109541995 @default.
- W4322774714 hasConcept C121608353 @default.
- W4322774714 hasConcept C159110408 @default.
- W4322774714 hasConcept C185592680 @default.
- W4322774714 hasConcept C202751555 @default.
- W4322774714 hasConcept C2775905019 @default.
- W4322774714 hasConcept C2776694085 @default.
- W4322774714 hasConcept C2777752497 @default.
- W4322774714 hasConcept C2781002465 @default.
- W4322774714 hasConcept C2781303535 @default.
- W4322774714 hasConcept C2994423619 @default.
- W4322774714 hasConcept C41685203 @default.
- W4322774714 hasConcept C530470458 @default.
- W4322774714 hasConcept C54355233 @default.
- W4322774714 hasConcept C55493867 @default.
- W4322774714 hasConcept C71240020 @default.
- W4322774714 hasConcept C71924100 @default.
- W4322774714 hasConcept C86803240 @default.
- W4322774714 hasConcept C96232424 @default.
- W4322774714 hasConcept C98274493 @default.
- W4322774714 hasConceptScore W4322774714C104317684 @default.
- W4322774714 hasConceptScore W4322774714C109541995 @default.
- W4322774714 hasConceptScore W4322774714C121608353 @default.
- W4322774714 hasConceptScore W4322774714C159110408 @default.
- W4322774714 hasConceptScore W4322774714C185592680 @default.
- W4322774714 hasConceptScore W4322774714C202751555 @default.
- W4322774714 hasConceptScore W4322774714C2775905019 @default.
- W4322774714 hasConceptScore W4322774714C2776694085 @default.
- W4322774714 hasConceptScore W4322774714C2777752497 @default.
- W4322774714 hasConceptScore W4322774714C2781002465 @default.
- W4322774714 hasConceptScore W4322774714C2781303535 @default.
- W4322774714 hasConceptScore W4322774714C2994423619 @default.
- W4322774714 hasConceptScore W4322774714C41685203 @default.
- W4322774714 hasConceptScore W4322774714C530470458 @default.
- W4322774714 hasConceptScore W4322774714C54355233 @default.
- W4322774714 hasConceptScore W4322774714C55493867 @default.
- W4322774714 hasConceptScore W4322774714C71240020 @default.
- W4322774714 hasConceptScore W4322774714C71924100 @default.
- W4322774714 hasConceptScore W4322774714C86803240 @default.
- W4322774714 hasConceptScore W4322774714C96232424 @default.